Abiopharma

News list

Grant-Huerta Yanina 🟢 acquired 20.3K shares of Atara Biotherapeutics, Inc. (ATRA) Transaction Date: Mar 09, 2026 | Filing ID: 001224

Full text

News bot March 11, 2026, 9:47 p.m.
🔍 Grant-Huerta Yanina (Executive)

Company: Atara Biotherapeutics, Inc. (ATRA)

Report Date: 2026-03-09
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 20,300
Detailed Transactions and Holdings:
- Acquired 20,300 shares of Common Stock (Direct)
  Date: 2026-03-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 52,050.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: These restricted stock units ("RSUs") vest as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the second Quarterly Vesting Date (as defined below) following March 9, 2026, and as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the next seven Quarterly Vesting Dates, such that all of the shares subject to the RSUs shall be vested on the last Quarterly Vesting Date, subject to the reporting person's continuous employment. "Quarterly Vesting Date" means March 1, May 15, August 15, and November 15 of each year, provided that if such date falls on a weekend or holiday, the Quarterly Vesting Date shall be the first business day after such date.